Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Diphenhydramine Citrate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 105Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PLD Acquisitions Generic Diphenhydramine Citrate:Ibuprofen Receives Approval In US
    PLD Acquisitions Generic Diphenhydramine Citrate:Ibuprofen Receives Approval In US

    11 Apr 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211404

    FDA
    11 Apr 2024
    Share Share
    FDA Confirms Paragraph IV Patent Challenge of Advil PM(Ibuprofen and Diphenhydramine Citrate) Tablets
    FDA Confirms Paragraph IV Patent Challenge of Advil PM(Ibuprofen and Diphenhydramine Citrate) Tablets

    03 Mar 2018

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-advil-pmibuprofen-and-diphenhydramine-citrate-tablets-1520055993.pdf

    FDA
    03 Mar 2018
    Share Share
    FDA Confirms Paragraph IV Patent Challenge of Advil PM (Ibuprofen and Diphenhydramine Citrate) Capsules
    FDA Confirms Paragraph IV Patent Challenge of Advil PM (Ibuprofen and Diphenhydramine Citrate) Capsules

    19 Jul 2017

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-advil-pm-ibuprofen-and-diphenhydramine-citrate-capsules-1500527011.pdf

    FDA
    19 Jul 2017
    Share Share